Regulation of adaptive immune responses to malaria infection by host and parasite MIF: implications for therapeutic strategies. 01/09/2024 - 31/08/2028

Abstract

The inability to acquire protective immunity against Plasmodium parasite infections is a significant obstacle to malaria control. Previous research has shown that Plasmodium parasites use an active mechanism to control the host immune response by expressing a molecule called PMIF, which is similar to the host macrophage migration inhibitory factor. Mutant parasites that lack PMIF have been shown to inhibit both cellular and humoral immune responses. However, the precise way in which parasite PMIF inhibits host MIF and host immune responses is not yet fully understood. This project aims to investigate the complex interplay between host and parasite-derived MIF molecules and their impact on the acquisition of protective immunity, as well as improving current and future therapeutic interventions. To achieve this, the following specific aims will be pursued: 1) Understanding the molecular basis of pro-inflammatory activation of T cell responses by host MIF and PMIF, 2) Determining the contribution of MIF molecules to the induction of Plasmodium antigen recognition and recall responses during liver and blood infection, and 3) Examining the impact of MIF functional polymorphism on the acquisition of sterile immunity against malaria. 1246

Researcher(s)

Research team(s)

Project type(s)

  • Research Project